Therefore mortality of PNS may be reduced with rapid antibody detection, early treatment, and a standard immunotherapy protocol. Another notable finding was that positivity for extracellular and synaptic antibodies predicted good prognosis and immunotherapy responsiveness but not mortality. (1 case) and Zic4 (1 case). Associated neurological syndromes were limbic encephalitis (8 instances), subacute cerebellar degeneration (7 instances), brainstem encephalitis (5 instances), subacute sensory neuronopathy (4 instances), stiff-person syndrome (2 instances) and opsoclonus-myoclonus (1 case). A tumor (ductal breast, small cell lung malignancy) was recognized in six instances at first admission. Six individuals died in an average follow-up time of 1 1.01.5 years. Detection of antibodies to extracellular or synaptic target antigens, but not presence of tumor, cranial MRI lesions or OCB, was associated with good prognosis and response to treatment. == Summary: == Zonampanel NMDAR, Hu and Ma2-antibodies were the most common ANA with this 1st antibody screening study inside a Turkish cohort. Antibody type was identified to become the foremost prognostic factor in ANA seropositive instances. Keywords:Paraneoplastic, antibody, survival, prognosis, malignancy == Intro == Paraneoplastic neurological syndrome (PNS) is definitely FAG a rare neurological condition and comprises a group of syndromes that can affect any part of the nervous system. Although PNS happens in malignancy individuals, majority of the individuals do not show a detectable tumor at the time of admission. Therefore, analysis is made with demonstration of a classical PNS (e.g. limbic encephalitis, subacute cerebellar degeneration, and subacute sensory neuronopathy), and detection of well-characterized cancer-related anti-neuronal antibodies (ANA) (e.g. Hu, Yo, and Ma2 Zonampanel antibodies) (13). ANA will also be recognized in non-paraneoplastic autoimmune encephalitis individuals, and constitute one of the hallmark findings of diagnostic criteria (4). Analysis of PNS and autoimmune encephalitis requires elimination of additional acute encephalopathy-associated pathogenic mechanisms such as metastasis, opportunistic infections, vascular events, and side effects of malignancy treatment (14). The significance of ANA in analysis of paraneoplastic and autoimmune neurological syndromes is definitely well recognized, and presence of ANA directed against cell surface antigens has been associated with good response to immunosuppressive treatment and beneficial analysis (3). However, there are only a few publications on the influence of ANA and additional diagnostic laboratory methods within the long-term prognosis, and survival of PNS and autoimmune encephalitis instances. In this study, we targeted to define regularly experienced ANA types, and connected neurological syndromes in the Turkish human population, and analyze the effect of laboratory findings obtained at admission to the long-term prognosis of ANA seropositive individuals. == METHODS == == Individuals == Twenty-seven consecutive instances with ANA were included in the study. All individuals fulfilled the diagnostic criteria for PNS (1), or autoimmune encephalitis (4). Since underlying Zonampanel tumors are often not recognized during the initial demonstration of neurological symptoms, presence of malignancy is not necessary for PNS analysis. PNS criteria require presence of malignancy, and/or well-characterized (Hu, Yo, Ri, Ma2, CV2 and amphiphysin) ANA in instances with classical PNS (e.g. limbic encephalitis, subacute cerebellar degeneration, subacute sensory neuronopathy and opsoclonus-myoclonus syndrome). In non-classical PNS (e.g. brainstem encephalitis, or stiff-person syndrome), detection of a well-characterized ANA is sufficient for the analysis. In non-classical PNS instances without a well-characterized ANA (e.g. Zic4), detection of an underlying tumor is also required for certain analysis (1). All individuals underwent a detailed neurological and systemic exam. The worst (maximum) and the last revised Rankin score (mRS) ideals, cranial MRI, and cerebrospinal fluid (CSF) oligoclonal band (OCB) findings were recorded. Only laboratory findings obtained during the initial admission of the patient were used in statistical analyses carried out to delineate prognostic ideals of laboratory methods. Cranial MRI was not performed in two individuals with subacute sensory neuronopathy due to the absence of central nervous system symptoms. A detailed laboratory and imaging protocol was performed for removal of non-paraneoplastic etiologies. A standard immunotherapy protocol Zonampanel was applied to all instances. Immunotherapy was initiated in conjunction with tumor resection in instances having a detectable.